429 results on '"Singh, Steven"'
Search Results
2. Napier couples celebrate 60 glittering years
3. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
4. Imaging modality for left ventricular ejection fraction estimation and effect of implantable cardioverter-defibrillator on mortality in patients with heart failure
5. Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial.
6. Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction.
7. Digoxin Use and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
8. Efficacy and Safety of Implantable Cardioverter Defibrillator (ICD) Implantation in the Elderly (The I-70 Study)
9. Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
10. Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
11. Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection Fraction
12. Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.
13. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction
14. Outcomes of Premature Ventricular Contraction–Cardiomyopathy in the Veteran Population: A Secondary Analysis of the CHF-STAT Study
15. Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation
16. Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial
17. Detection and Management of Geographic Disparities in the TOPCAT Trial Lessons Learned and Derivative Recommendations
18. Discharge Hospice Referral and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries Hospitalized for Heart Failure
19. TRAIL-receptor 2—a novel negative regulator of p53
20. Abstract 17121: Initiation of Anti-Hypertensive Therapy and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) and a History of Hypertension (HTN)
21. Opioid Use and Outcomes in Hospitalized Older Patients With Heart Failure Receiving and Not Receiving Hospice Referrals
22. Abstract 14667: Amiodarone is an Effective Treatment of PVC-Cardiomyopathy in the Veteran Population
23. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: A substudy of the SAFE-T trial
24. Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism
25. Outcomes of Premature Ventricular Contraction-Cardiomyopathy in the Veteran Population: A Secondary Analysis of the CHF-STAT Study
26. Exercise capacity in atrial fibrillation: A substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T)
27. Nonsustained ventricular tachycardia in dilated cardiomyopathy
28. The association of the heart failure score with mortality and heart failure hospitalizations in elderly patients: insights from the Mode Selection Trial (MOST)
29. Antiarrhythmic drugs
30. Trials of New Antiarrhythmic Drugs for Maintenance of Sinus Rhythm in Patients with Atrial Fibrillation
31. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure
32. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004
33. Amiodarone versus sotalol for atrial fibrillation
34. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)
35. Role of Dofetilide in Patients with Atrial Fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study
36. Contributors
37. Evaluation and Management of Arrhythmias Associated with Congestive Heart Failure
38. Ventricular arrhythmias in heart failure: link to haemodynamic load
39. Quality of Life and Exercise Performance in Patients in Sinus Rhythm Versus Persistent Atrial Fibrillation: A Veterans Affairs Cooperative Studies Program Substudy
40. QRS duration and mortality in patients with congestive heart failure
41. POOR OUTCOMES ASSOCIATED WITH DIGOXIN DISCONTINUATION IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) MAY DIFFER BY BETA-BLOCKER USE
42. DIGOXIN INITIATION IS NOT ASSOCIATED WITH ALL-CAUSE MORTALITY IN PATIENTS WITH HEART FAILURE AND ATRIAL FIBRILLATION: INSIGHTS FROM THE MEDICARE-LINKED OPTIMIZE-HF REGISTRY
43. Intrathoracic Impedance Preceding Ventricular Tachyarrhythmia Episodes
44. Pseudoaneurysm of mitral–aortic intervalvular fibrosa: two case reports and review of literature
45. Emerging drugs for atrial fibrillation
46. Exercise Capacity and All-Cause Mortality in African American and Caucasian Men With Type 2 Diabetes
47. Implantable Cardioverter Defibrillator Therapy and the Need for Concomitant Antiarrhythmic Drugs
48. Exercise Pulse Pressure Predicts Severity of Angiographically Determined Coronary Artery Disease: 2382: Board #61 June 1 2:00 PM - 3:30 PM
49. Diastolic Function in Young Patients with Beta-Thalassemia Major: An Echocardiographic Study
50. Combination of a Sterol Absorption Inhibitor and Cardiovascular Agents for the Treatment of Dyslipidemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.